Skip to main content
Clinical Trials/JPRN-UMIN000028269
JPRN-UMIN000028269Completed未知

A verification study on improvements in the immune system and defecation: A randomized open-label trial - A verification study on improvements in the immune system and defecation

ORTHOMEDICO Inc.0 sites93 target enrollmentStarted: July 18, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
93

Study Overview

Brief Summary

Shimono T, Hoshino T, Takahashi Y, Takara T. Synbiotics Containing Bifidobacterium longum BB536 improve bowel movements and enhance immunity in elderly people-A randomized, open-label, parallel-group study-. Jpn Pharmacol Ther. 2020; 48(7): 1167-1177

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
65years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Those who have the medical history or under the treatment of malignant tumor 2. Those who have the medical history or under the treatment of autoimmune disease 3. Those who have the medical history or under the treatment of inflammatory bowel disease 4. Those who are currently hospitalized 5. Those who use or take "Foods for Specified Health Uses" and "Foods with Functional Claims" in daily 6. Those who eat Natto, yogurt, and food and beverage including lactic acid bacteria in daily 7. Those who are smokers 8. Those who take anti-allergic drugs 9. Those who take laxative tablets 10. Those who are currently taking supplements 11. Those who are allergic to medicines and/or the test food related products 12. Those who are pregnant, breast-feeding, and plan to become a pregnant 13. Those who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 14. Others considered as inappropriate for the study by the physician

Investigators

Similar Trials